Unichem Laboratories gets USFDA nod to market muscle spasm tablets

Unichem Laboratories gets USFDA nod to market muscle spasm tablets
Unichem Laboratories gets USFDA nod to market muscle spasm tablets The company has received abbreviated new drug application (ANDA) approval to market its Cyclobenzaprine Hydrochloride tablets USP 5 mg, 7.5 mg and 10 mg from the United States Food and Drug Administration (USFDA), Unichem Labs said in a filing to the BSE.